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【Abstract】 Objective: To investigate the possible mechanisms in acupuncture analgesia by 
interaction of δ-opioid receptor with neurotransmitter transport proteins or the Na+-K+ pump. 
Methods: Microinjection of respective heterologous cRNA into the Xenopus oocytes as a 
model system, and measurement of steady-state currents under two-electrode voltage clamp.  
Results: The co-expression of the δ-opioid receptor with GAT1, EAAC1 or the sodium pump 
resulted in reducing activity of the respective transporter. Opioid receptor activation affected 
transporter activity in different ways: 1) GAT1 was further inhibited; 2) EAAC1 was stimulated; 
3) Na+-K+ pump activity interfered with agonist sensitivity of DOR. Pump inhibition led to 
higher sensitivity for DPDPE. Conclusion: GABA transporter inhibition and glutamate 
transporter stimulation may counteract pain sensation by affecting the neurotransmitter 
concentration in the synaptic cleft and, therefore, may contribute synergistically to pain 
suppression by acupuncture. Sodium pump inhibition by endogenous ouabain may amplify 
these effects. These synergistic effects may be the molecular mechanism of inhibiting pain sense 
and/or acupuncture analgesia.  
【Key Words】Acupuncture Analgesia; Receptors, Opioid; Neurotransmitter Transport Proteins; 
Protein Interaction Domains and Motifs 
【CLC Number】R2-03 
【Document Code】A 
Fund Items: the Science Foundation of Shanghai Municipal Commission of Science and Technology (05DZ19745, 06DZ19732, 
064319053, 07DZ19722, 07DZ19733), the National Basic Research Program of China (973 Program, 2005CB523306) and Shanghai 
Leading Academic Discipline Project (B112 and T0302) 
Author: YANG Zhi-jie, 42 years old, associate researcher, research Interest are cellular mechanisms of acupuncture analgesia and 
moxibustion 
Corresponding Author: Wolfgang SCHWARZ, 65, Professor at Goethe University,Frankfurt am Main, Germany. Research Interest: 
cellular electrophysiology inacupuncture and Chinese Medicine research 
J. Acupunct. Tuina. Sci. (2008) 6: 298-300  
Copyright © 2008 Shanghai Research Institute of Acupuncture and Meridian︱● 299 ● 
Neurotransmitter transporters play a key role in the 
regulation of synaptic transmission. In the 
mammalian brain the dominating excitatory neuro- 
transmitter is glutamate, the dominating inhibitory 
neurotransmitter GABA. These transporters are 
driven by the inward-directed gradient for sodium 
which is maintained by the electrogenic Na+-K+ 
ATPase. Hence, regulation of the Na+-K+ ATPase (or 
sodium pump) plays a crucial role in nerve 
excitability as well as synaptic transmission. It is 
generally accepted that pain sensation can be 
suppressed by acupuncture, and it has been 
demonstrated that acupuncture in its analgesic effect 
interferes with the glutamatergic system[1]. 
Experiments with transgenic mice with knock-out or 
over expressed GABA transporter have demonstrated 
that the GABA transporter is involved in pain 
sensation[2]. Therefore, the authors may speculate that 
modulation in the activity of the transporters for 
glutamate and GABA as well as the sodium pump 
may be involved in the mechanism of pain 
suppression by acupuncture. It has been suggested 
that acupuncture leads to the activation of 
enkephalinergic neurons. The authors, therefore, 
investigated the interaction of δ-opioid receptors with 
the glutamate transporter EAAC1, with the GABA 
transporter GAT1 and the Na+-K+ ATPase. The results 
support the idea that all these membrane transporters 
may be involved in pain sensation, and that they may 
form a target for acupuncture. 
 
1 Material and Methods 
For investigating possible interference of enkepha- 
linergic receptors and the transporters mentioned 
above, the authors used Xenopus oocytes as a model 
system with heterologously co-expressed δ-opioid 
receptors together with one of the neurotransmitter 
transporters or the soidum pump, respectively. For 
detecting effects on transport the authors analyzed 
steady-state currents mediated by these electrogenic 
transporters in voltage-clamp experiments 
 
2 Results 
2.1 Interaction of Na-K pump and co-expression of 
δ-opioid receptors 
Expression of the δ-opioid receptor (DOR) results 
in reduction of endogenous sodium-pump activity. 
Stimulation of DOR by the DOR agonist [D-Pen2,5]- 
enkephalin (DPDPE) had no pronounced additional 
effect on pump activity. Qualitatively similar results 
were obtained in experiments with a variety of 
co-expressed exogenous sodium pumps.  The 
authors suggest that reduced pump activity with DOR 
expression is brought about by an interaction of the 
pump with DOR. Direct interaction is also supported 
by co-immunoprecipitation. The interaction may be 
responsible for altered agonist sensitivity of DOR, 
activation of the sodium pump led to an increase of 
the Km value for DOR activation by DPDPE from 
about 165 nM to 320 nM (Fig. 1). 
Fig.1. Dependence of DPDPE-induced current (at -100 mV) on 
DPDPE concentration 
 (Open circle: blocked, filled circled stimulated pump) 
2.2 Expression and activation of δ-opioid receptor 
regulates the activity of GABA transporter GAT1 
Function of GAT1 was analyzed in terms of 
Na+-dependent [3H] GABA uptake as well as 
steady-state and transient currents mediated by the 
GAT1 in the oocytes. The number of functionally 
expressed GAT1 was calculated from the transient 
charge movements associated with extracellular Na+ 
binding.  Co-expression of DOR led to a reduced 
number of fully functional transporters in the oocyte 
surface membrane though the total amount of 
expressed GAT1 was not affected by the co- 
expression of DOR as judged by Western blotting. In 
addition to the reduced functional expression, even 
further reduced substrate-translocation rate was 
detected. Activation of DOR by DPDPE further 
reduced the GAT1-mediated current, without 
significant effect on the rate of GABA uptake.  
Co-expression of µOR as well as activation of the 
receptor by 100 nM of the specific agonist DAMGO 
affected neither the number of transporters, nor the 
rate of GABA uptake, nor the GAT1-mediated 
current. 
2.3 Regulation of the glutamate transporter 
EAAC1 by expression and activation of δ-opioid 
receptor  
δ-opioid receptor co-expressed with EAAC1 in 
Xenopus oocytes, but not the μ-opioid receptor, 
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down-regulated EAAC1 function, and DPDPE 
stimulation of DOR can counteract the down 
regulation of the EAAC1-mediated uptake. Results 
from co-immunoprecipitation and immunofluo- 
rescence microscopy in both oocytes and rat 
hippocampal neurons indicated co-localization and 
suggest direct interaction between DOR and 
EAAC1[3]. The results suggest that the DOR can 
reduce EAAC1 function by direct protein-protein 




The authors conclude that DOR can specifically 
and directly interfere with a variety of membrane 
transport systems including the sodium pump, GAT1, 
and EAAC1. The results suggest that pump activity 
not only affects neural activity directly but also 
through functional interaction with DOR and hence 
will modulate pain sensation. For GAT1, the 
interaction with DOR lead to the inactivation of 
GAT1.  Activation of the DOR leads, most likely 
through G-protein coupled signaling pathways, to 
further reduction of GAT1-mediated current not 
coupled to the GABA transport.  These regulatory 
mechanisms of GAT1 by DOR suggest interaction 
between the GABAergic system and opioid receptors, 
which contribute to opiate addiction as well as pain 
sensation. 
The results suggest that direct protein-protein 
interaction also between DOR and EAAC1 might be 
responsible for the reduced function of EAAC1, and 
that activation of DOR releases the inhibitory 
interaction. The authors suggest that this mechanism 
might be important for modulation of the 
glutamatergic system after opioid stimulation. 
In conclusion, the GABA transporter inhibition and 
the glutamate transporter stimulation may counteract 
pain sensation by affecting the neurotransmitter 
concentration in the synaptic cleft and, therefore, may 
contribute synergistically to pain suppression by 
acupuncture. Sodium pump inhibition by endogenous 
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● Short Report ● 
Effect of Different Laser on Rats with Hypolekocytosis 
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Objective: To assess the effect of 10.6 μm laser and 650 nm laser simultaneous or separate irradiation on 
rats with hypolekocytosis. Methods: 60 Wistar Rats, 50% male and 50% female with normal white cell 
count (WBC) in blood and weight 180-220g, were randomly allocated to control, model, sham laser, 10.6μm 
laser, 650 nm laser and 10.6 μm+650 nm laser group, 10 in each group. The hypolekocytosis model was 
established by i.p. cyclophosphamide100g/kg weight. Corresponding laser irradiation was administration on 
Zusanli (ST 36) and Dazhui (GV 14) for 1 min, once per day, 8 times totally. The WBC in blood collected 
from tail end every two days after the model was established was taken as assess index. Results: The WBC 
of rats decreased continuely from the second day after injected cyclophosphamide, and to the lowest level on 
the fifth day, then began to recover. The WBC of 10.6 μm +650 nm laser group reached the normal level 
after 8 times laser irradiation, and had no difference with the control group (P>0.01), but the model, sham 
laser, 10.6 μm laser and 650 nm laser group had very significant difference with the control group (P<0.001). 
Conclusion: 10.6 μm CO2 laser and 650 nm semiconductor laser simultaneously irradiating Zusanli (ST 36) 
and Dazhui (GV 14) can accelerate the recovery of the WBC in the rat with hypolekocytosis. But neither 
10.6 μm CO2 laser nor 650 nm semiconductor laser irradiation can does it. Therefore it is suggested that a 
synergetic effect can be induced when the both lasers irradiate simultaneously. 
